The present study highlights that MS in older adults is associated with substantially increased release of systemic pro-inflammatory mediators such as IL-1beta, IL-8, TNF-alpha, leptin, and the pro-fibrotic mediator, VEGF, when compared to older adults without MS. This evidence concerns the gene TNF and myeloid sarcoma.